AMLX — AMYLYX PHARMACEUTICALS INC

Ownership history in BRAIDWELL LP  ·  1 quarter on record

This page tracks every 13F SEC filing in which BRAIDWELL LP reported a position in AMYLYX PHARMACEUTICALS INC (AMLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.25% (2025 Q3)
Avg. % of fund
0.25%
First filed
2025 Q3
Last filed
2025 Q3
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 INITIATED 612,841 — — 0.25% $8.3M $13.59
% of Fund (quarterly)    AMLX price (monthly, adj. close)

Other funds also holding AMLX

As of 2025 Q4 — sorted by position size

Saturn V Capital Management LP 3Y 9.97% GREAT POINT PARTNERS LLC 3Y 7Y 6.85% Almitas Capital LLC 3Y 7Y 5.65% Commodore Capital LP 3Y 4.54% First Light Asset Management, LLC 3Y 7Y 3.1% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 2.73% TCG Crossover Management, LLC 3Y 2.5% Aldebaran Capital, LLC 3Y 2.15% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.78% STEMPOINT CAPITAL LP 1.17%
← Back to BRAIDWELL LP Holdings